Orthobiologics Market Size, Share & Industry Analysis
商品番号 : SMB-67470
| 出版社 | Fortune Business Insights |
| 出版年月 | 2024年10月 |
| ページ数 | 181 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,850 |
| 種別 | 英文調査報告書 |
Growth Factors of Orthobiologics Market
The orthobiologics market size was valued at USD 8.77 billion in 2023, and the market is now projected to grow from 9.22 billion in 2024 to USD 14.42 billion by 2032, exhibiting a CAGR of 5.7% during the forecast period of 2024-2032.
オルトバイオロジクスの市場規模は2023年に87億7,000万米ドルと評価されており、現在市場は2024年の92億2,000万米ドルから2032年までに144億2,000万米ドルに成長すると予測されており、2024年から2032年の予測期間中に5.7%のCAGRを示しています。
COVID 19 affected orthobiologics market worldwide affecting supply chain and Elective surgeries caused by lock down measures. Due to the COVID-19 breakout, many hospitals shifted their focus to treat COVID patients and a large number of elective surgeries including orthopaedic, orthobiologics got delayed, thus reducing the market of orthobiologics products. However, there has been a boost in the sector after the COVID increased concentration on the recovery of the patients after admissions. Further, growth in the healthcare technology front such as telemedicine and remote patient monitoring during covid has paved way for orthobiologics to come up with new ideas and innovations when adapting to the new future.
The orthobiologics market has experienced few key characteristics; some of the advancements include regenerative medicine procedures like stem cell therapy and platelet-rich plasma (PRP) therapy. High demands for minimally invasive surgery have lead to the creation of new delivery methods for orthobiologics. Not only has specialization in biomaterials improved the effectiveness of treatments, but this knowledge leads to better outcomes. While technology like 3D printing and the application of artificial intelligence is also influencing the form of product design and custom treatment options. In order to sum, these trends depict better patient centric approach and improved recovery solutions. Thus, all the above mentioned factors are contributing towards the veterinary diagnostics market growth.
There are several market drivers contributing to the growth of orthobiologics market today these include increased incidence of musculoskeletal disorder, increased population and advances in technology. Progress made in the use of stem cells, tissue engineering and other applications improve the prospects for development of orthobiologics. Furthermore, increasing demand for minimally invasive products by patients and physicians experience is also driving the market. Higher levels of research and development spending by global pharmaceuticals and biotechnology industries are also enhancing the pace of innovation in this segment, and the subsequent launch of value-added products and therapies.
Comprehensive Analysis Orthobiologics Market
For segmentation purpose, the orthobiologics market has been divided based on product type, application and end use. Some of the most important products are: joint therapies such as visco-supplements that down regulates joint pain; growth factors for bone healing; DBM; synthetic bone grafts; and cellular allograft for instance. In terms of applications, it operates in spinal fusion, maxillo facial / dental, soft tissue repair, reconstructive/ fracture surgeries and many others. The targets are hospitals and ambulatory surgical centers (ASCs), reprocessing specialty clinics, and other user facilities that demonstrate a wide range of orthobiologics applications to multiple patient populations.
North America has the strongest market for orthobiologics due to social factors such as; well-developed health system, high health care costs and increasing frail of geriatric population who are prone to orthobiologics requirement diseases. The region has excellent R&D investments to support growth in regenerative medicine and orthobiologics products. Moreover, the strong growth of key market players, trump card medical facilities raises the acceptance levels of new technological treatments. Sports injuries are more and more common and there is a higher demand for using orthobiologics as an endovenous treatment which also explain why North America leads the orthobiologics market in the world.
Key players in this sector include Medtronic (Ireland), Zimmer Biomet (U.S.), DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.), Stryker (U.S.), Anika Therapeutics, Inc. (U.S.), SeaSpine (U.S.), Bioventus (U.S.), RTI Surgical (U.S.), MTF Biologics (U.S.)
One of the most observed trends in the orthobiologics market in 2023 is an increased utilization of various highly-developed cellular therapies with Particular Focus on Stem Cells. The use of these therapies in furthering recovery in orthopedic operations is gradually gaining acceptance. Business are paying attention on creation of products containing adipose-derived stem cells and bone marrow aspirate for better regenerative results in conditions linked with osteoarthritis and tendon disorders. This transition to molecular biology based medicine as a result of developing bio-processing and cellular technologies is however an indication of an increasing focus on the use of more efficient treatment protocols in orthobiologics.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 5.7% from 2024-2032
Unit Value (USD billion)
Segmentation
By Product Type
- Viscosupplements
- Bone Growth Factors
- Demineralized Bone Matrix (DBM)
- Synthetic Bone Substitutes
- Cellular Allograft
- Others
By Application
- Spinal Fusion
- Maxillofacial & Dental
- Soft Tissue Repair
- Reconstructive & Fracture Surgery
- Others
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
By Geography
- North America (By Product Type, By Application, By End-user, and By Country)
o U.S. (By Application)
o Canada (By Application)
- Europe (By Product Type, By Application, By End-user, and By Country/Sub-region)
o Germany (By Application)
o U.K. (By Application)
o France (By Application)
o Italy (By Application)
o Scandinavia (By Application)
o Rest of Europe (By Application)
- Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-region)
o China (By Application)
o India (By Application
o Japan (By Application)
o Australia (By Application)
o Southeast Asia (By Application)
o Rest of Asia Pacific (By Application)
- Latin America (By Product Type, By Application, By End-user, and By Country/Sub-region)
o Brazil (By Application)
o Mexico (By Application)
o Rest of Latin America (By Application)
- Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-region)
o South Africa (By Application)
o GCC (By Application)
o Rest of Middle East & Africa (By Application)
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Epidemiology of Clinical Indications
4.2. Regulatory Scenario for Key Countries
4.3. New Product Launches
4.4. Key Industry Developments (Mergers, Acquisitions, and Partnership)
4.5. Impact of COVID-19 on the Market
5. Global Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Viscosupplements
5.1.2. Bone Growth Factors
5.1.3. Demineralized Bone Matrix (DBM)
5.1.4. Synthetic Bone Substitutes
5.1.5. Cellular Allograft
5.1.6. Allografts
5.1.7. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Spinal Fusion
5.2.2. Maxillofacial & Dental
5.2.3. Soft Tissue Repair
5.2.4. Reconstructive & Fracture Surgery
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Hospitals & ASCs
5.3.2. Specialty Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Viscosupplements
6.1.2. Bone Growth Factors
6.1.3. Demineralized Bone Matrix (DBM)
6.1.4. Synthetic Bone Substitutes
6.1.5. Cellular Allograft
6.1.6. Allografts
6.1.7. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Spinal Fusion
6.2.2. Maxillofacial & Dental
6.2.3. Soft Tissue Repair
6.2.4. Reconstructive & Fracture Surgery
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By End-user
6.3.1. Hospitals & ASCs
6.3.2. Specialty Clinics
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.1.1. By Application
6.4.2. Canada
6.4.2.1. By Application
7. Europe Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Viscosupplements
7.1.2. Bone Growth Factors
7.1.3. Demineralized Bone Matrix (DBM)
7.1.4. Synthetic Bone Substitutes
7.1.5. Cellular Allograft
7.1.6. Allografts
7.1.7. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Spinal Fusion
7.2.2. Maxillofacial & Dental
7.2.3. Soft Tissue Repair
7.2.4. Reconstructive & Fracture Surgery
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By End-user
7.3.1. Hospitals & ASCs
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. Germany
7.4.1.1. By Application
7.4.2. U.K.
7.4.2.1. By Application
7.4.3. France
7.4.3.1. By Application
7.4.4. Italy
7.4.4.1. By Application
7.4.5. Spain
7.4.5.1. By Application
7.4.6. Scandinavia
7.4.6.1. By Application
7.4.7. Rest of Europe
7.4.7.1. By Application
8. Asia Pacific Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Viscosupplements
8.1.2. Bone Growth Factors
8.1.3. Demineralized Bone Matrix (DBM)
8.1.4. Synthetic Bone Substitutes
8.1.5. Cellular Allograft
8.1.6. Allografts
8.1.7. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Spinal Fusion
8.2.2. Maxillofacial & Dental
8.2.3. Soft Tissue Repair
8.2.4. Reconstructive & Fracture Surgery
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By End-user
8.3.1. Hospitals & ASCs
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. China
8.4.1.1. By Application
8.4.2. India
8.4.2.1. By Application
8.4.3. Japan
8.4.3.1. By Application
8.4.4. Australia
8.4.4.1. By Application
8.4.5. Southeast Asia
8.4.5.1. By Application
8.4.6. Rest of Asia Pacific
8.4.6.1. By Application
9. Latin America Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Viscosupplements
9.1.2. Bone Growth Factors
9.1.3. Demineralized Bone Matrix (DBM)
9.1.4. Synthetic Bone Substitutes
9.1.5. Cellular Allograft
9.1.6. Allografts
9.1.7. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Spinal Fusion
9.2.2. Maxillofacial & Dental
9.2.3. Soft Tissue Repair
9.2.4. Reconstructive & Fracture Surgery
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By End-user
9.3.1. Hospitals & ASCs
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.4.1. Brazil
9.4.1.1. By Application
9.4.2. Mexico
9.4.2.1. By Application
9.4.3. Rest of Latin America
9.4.3.1. By Application
10. Middle East & Africa Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product Type
10.1.1. Viscosupplements
10.1.2. Bone Growth Factors
10.1.3. Demineralized Bone Matrix (DBM)
10.1.4. Synthetic Bone Substitutes
10.1.5. Cellular Allograft
10.1.6. Allografts
10.1.7. Others
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Spinal Fusion
10.2.2. Maxillofacial & Dental
10.2.3. Soft Tissue Repair
10.2.4. Reconstructive & Fracture Surgery
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By End-user
10.3.1. Hospitals & ASCs
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. South Africa
10.4.1.1. By Application
10.4.2. GCC
10.4.2.1. By Application
10.4.3. Rest of Middle East & Africa
10.4.3.1. By Application
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Medtronic
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Zimmer Biomet
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Stryker
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Anika Therapeutics, Inc.
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. SeaSpine
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Bioventus
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. RTI Surgical
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. MTF Biologics
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Arthrex, Inc.
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. Smith & Nephew
11.2.11.1. Overview
11.2.11.2. Products
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)
Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス ※レポートタイトルにより異なる場合がございます。詳細はお問合せください。
- シングルユーザライセンス
- 提供ファイル：PDF（印刷不可）
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート